Cargando…
Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
BACKGROUND: Lung neuroendocrine tumors account for approximately 15% of all lung cancer cases. LNET are subdivided into typical carcinoid (TC), atypical carcinoid (AC), large cell neuroendocrine carcinoma (LCNEC), and small-cell lung cancer (SCLC). The Ki-67 index has been used for decades to evalua...
Autores principales: | Orozco-Morales, Mario, Avilés-Salas, Alejandro, Hernández-Pedro, Norma, Catalán, Rodrigo, Cruz-Rico, Graciela, Colín-González, Ana Laura, Dosal-Mancilla, Elsa, Barrios-Bernal, Pedro, Arrieta, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214491/ https://www.ncbi.nlm.nih.gov/pubmed/34195295 http://dx.doi.org/10.1155/2021/6632249 |
Ejemplares similares
-
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
por: Arrieta, Oscar, et al.
Publicado: (2020) -
CD47-SIRPα Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer
por: Catalán, Rodrigo, et al.
Publicado: (2020) -
Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
por: Orozco-Morales, Mario, et al.
Publicado: (2016) -
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
por: Avilés-Salas, Alejandro, et al.
Publicado: (2022) -
Modifying factors of PD‐L1 expression on tumor cells in advanced non‐small‐cell lung cancer
por: Avilés‐Salas, Alejandro, et al.
Publicado: (2022)